Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Equity Ratio (2019 - 2025)

Eton Pharmaceuticals (ETON) has disclosed Equity Ratio for 7 consecutive years, with 0.28 as the latest value for Q4 2025.

  • Quarterly Equity Ratio fell 11.52% to 0.28 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.28 through Dec 2025, down 11.52% year-over-year, with the annual reading at 0.28 for FY2025, 11.52% down from the prior year.
  • Equity Ratio hit 0.28 in Q4 2025 for Eton Pharmaceuticals, up from 0.22 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.69 in Q2 2021 to a low of 0.22 in Q3 2025.
  • Historically, Equity Ratio has averaged 0.48 across 5 years, with a median of 0.51 in 2022.
  • Biggest five-year swings in Equity Ratio: soared 383.21% in 2021 and later plummeted 50.37% in 2025.
  • Year by year, Equity Ratio stood at 0.64 in 2021, then fell by 18.6% to 0.52 in 2022, then dropped by 6.67% to 0.49 in 2023, then tumbled by 34.19% to 0.32 in 2024, then decreased by 11.52% to 0.28 in 2025.
  • Business Quant data shows Equity Ratio for ETON at 0.28 in Q4 2025, 0.22 in Q3 2025, and 0.24 in Q2 2025.